ArticleNeuro-oncology advances

Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma.

John Y Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.